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Abstract
With increasing numbers of children being diagnosed with neurodevelopmental disorders (NDDs) attention has been drawn 
to these children’s physical health. We aimed to identify the prevalence of defined physical problems (epilepsy, migraine, 
asthma, cancer, diabetes, psoriasis, lactose intolerance, celiac disease, diarrhea, constipation, daytime enuresis, encopresis) 
in a nationwide population of 9- and 12-year-old twins subdivided into those with and without indications of NDDs. Parents 
of 28,058 twins participated in a well-validated telephone interview regarding their children’s mental health and answered 
questions about their physical problems. The results indicate a high rate of physical problems in children with NDDs, par-
ticularly in those with indications of the presence of combinations of several NDDs.
Keywords Physical health · Neurodevelopmental disorders · Autism spectrum disorder (ASD) · Attention-deficit/
hyperactivity disorder (ADHD) · Learning disorder (LD) · Twins
Introduction
Neurodevelopmental disorder (NDD) is a term used in the 
diagnostic and statistical manual of mental disorders, fifth 
edition (AmericanPsychiatricAssociation 2013) to describe 
a range of disorders with symptom onset during childhood. 
NDDs include—among other disorders—Autism spectrum 
disorder (ASD), which is characterized by impairment in 
social communication and inflexibility in interests, behavior 
and imagination (Lai et al. 2014), attention-deficit/hyper-
activity disorder (ADHD), defined as problems with short 
attention span, impulsivity and/or hyperactivity (Pelham 
et al. 2005); and learning disorders (LD), most frequently 
displayed through symptoms of poor reading and/or writing 
ability (AmericanPsychiatricAssociation 2013).
The different NDDs share similar cognitive and behav-
ioral processes, and frequently overlap with each other (and 
with other mental health disorders), which makes a dimen-
sional approach to disorder classification useful (Anckarsater Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s1080 3-018-3697-4) contains 
supplementary material, which is available to authorized users.
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2010). With this in mind, ESSENCE (early symptomatic 
syndromes eliciting neurodevelopmental clinical examina-
tions) was introduced (Carlsson et al. 2013; Gillberg 2010) 
for the purpose of highlighting the significant amount of 
overlap across NDDs and the similarities of their symptoms 
mainly during young ages.
Recent research has shown a rise in the number of chil-
dren clinically diagnosed with NDDs (Boyle et al. 2011) 
and that these children often have coexisting physical prob-
lems (Schieve et al. 2012). Until now, most studies have 
focused on physical problems co-occurring with either 
ASD or ADHD, such as the association between autism 
and epilepsy, which has been documented in many studies 
(Amiet et al. 2008; Jokiranta et al. 2014; Reilly et al. 2014). 
Besides epilepsy, the increased prevalence of gastrointesti-
nal (GI) problems (Chaidez et al. 2014; McElhanon et al. 
2014; Valicenti-McDermott et al. 2006), eating problems 
(Rastam et al. 2013), diarrhea and constipation (Chaidez 
et al. 2014), headache (Parisi et al. 2014) and asthma (Kotey 
et al. 2014) has been shown in children with ASD. A poten-
tial link between celiac disease and ASD has been investi-
gated, but in most studies no such association has been found 
(Batista et al. 2012; Black et al. 2002; Lau et al. 2013). A 
case-control study reported elevated prevalence of specific 
immune-related comorbidities in ASD compared to controls; 
allergy, various autoimmune diseases and psoriasis (Zerbo 
et al. 2015). With regards to a link between type 1 diabe-
tes mellitus (T1DM) and ASD, the results are diverse. One 
study from Finland could not find any increased occurrence 
of ASD among 5178 children with T1DM (Harjutsalo and 
Tuomilehto 2006), whereas a retrospective descriptive US 
study in young adults with ASD found a small but statisti-
cally significant increase in the prevalence of T1DM in ASD 
patients compared to general hospital patients (Kohane et al. 
2012). A 35% increased risk of children with ASD to have 
asthma as compared to children in the general population 
was established in a large cross-sectional study in the United 
States (Kotey et al. 2014).
Some studies have shown increased prevalence of epi-
lepsy (Cohen et al. 2013), migraine (Fasmer et al. 2011) 
and asthma (Fasmer et al. 2011) in patients diagnosed with 
ADHD, and vice versa increased prevalence of ADHD in 
clinical populations of children with somatic problems. 
For example, in children with asthma a significantly higher 
risk of developing ADHD during the school years has been 
detected compared to children without asthma (Chen et al. 
2013). A recent Swedish study found that presence of 
ADHD made treatment of T1DM in teenagers a challenge 
(Lindblad et al. 2017) and a large epidemiological study 
found ADHD to be almost five times as common in chil-
dren with enuresis as compared to children without (von 
Gontard et al. 2011). Using Norwegian national registries, 
a cross-sectional study found a significant association 
between ADHD and psoriasis, especially in females (Heg-
vik et al. 2018). A recent review on somatic comorbidity 
among adults with ADHD found that asthma is a well-
documented comorbidity among adults with ADHD while 
the number of studies looking at the associations between 
ADHD and epilepsy, migraine, GI disorders and enuresis 
are still very few, ranging from one to three studies each 
(Instanes et al. 2018). A recent familial association case-
control study of 117 children and adolescents with DSM-5 
ADHD reported that a headache disorder diagnosis was 
common for both patients and healthy controls (59.0% vs. 
37.8%), and migraine was found in 26.0% of ADHD cases 
and 9.9% of healthy controls (Kutuk et al. 2018). A posi-
tive association between the prescription of anti-migraine 
and ADHD medications and higher prevalence of migraine 
was found among adults with ADHD in Norway (Fasmer 
et al. 2012). One clinical study reported an overrepresen-
tation of ADHD symptoms in patients with celiac disease 
(Niederhofer and Pittschieler 2006) and another study of 
patients with ADHD found an overrepresentation of celiac 
disease identified by the presence of celiac disease specific 
antibodies (Niederhofer 2011). In contrast, a large con-
trolled study could not confirm the association between 
celiac disease and ADHD in children (Gungor et al. 2013).
There are few studies investigating physical health 
issues in children with LD or to what extent LD may exist 
in children with physical diseases (Schieve et al. 2012). 
One population-based study in Taiwan showed that the 
most common comorbid NDD among children with epi-
lepsy was LD with a prevalence of 13% (Chiang and 
Cheng 2014). A Swedish study failed to show that chil-
dren with T1DM had impaired academic ability (McCa-
rthy et al. 2002).
In 2011, a population-based study was published investi-
gating coexisting medical conditions in children with diag-
noses of autism and/or ADHD (Schieve et al. 2012). This 
study found a moderate to high increase in the rate of most 
medical conditions examined in children with these NDDs. 
Phenotypical overlaps cannot be interpreted as causation or 
shared etiology per se, but a number of medical or genetic 
syndromes are known to cause physical problems and 
NDDs alike. Children with tuberous sclerosis have higher 
prevalence of ASD and learning disabilities (Mitchell et al. 
2017) and studies have shown an association between early 
exposure of cranial radiation or chemotherapy and later 
development of neurocognitive problems (Anderson and 
Kunin-Batson 2009; Edelstein et al. 2011), but still the field 
of NDD in cancer patients is relatively unexplored. Even 
though comorbidity of NDDs is the rule rather than the 
exception (Gillberg 2010), no study has of yet specifically 
investigated the physical health of children with multiple 
overlapping NDDs, nor does a comprehensive overview of 
these associations exist.
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In the present study, we used a Swedish nationwide gen-
eral population cohort of twins to examine (a) the relation-
ship between any “single” NDD and a variety of physical 
problems (epilepsy, migraine, asthma, cancer, diabetes, 
psoriasis, lactose intolerance, celiac disease, diarrhea, 
constipation, daytime enuresis, encopresis) and (b) if vari-
ous constellations of NDDs are differently associated with 
these defined physical problems. The study provides a map 
of phenotypical associations between NDDs and physical 
problems, but does not assess underlying etiological factors, 
such as gestational age, birth weight or genetic mechanisms.
Methods
Subjects
Participants were included from the ongoing Child and Ado-
lescent Twin Study in Sweden (CATSS) (Anckarsater et al. 
2011) that aims to track all twins born in Sweden from 1992 
and onwards. A telephone interview is conducted with the 
parents around the time of the children’s ninth birthday. The 
first three years of the CATSS interviews were conducted 
with parents of 12 year-old twins as well, to increase the 
number of birth cohorts included in the study. The entire 
CATSS-study has been described in detail in an overview 
article (Anckarsater et al. 2011). The present study com-
prises data on 28,058 children (all twins) born between the 
31st of June 1992 through the 31st of December 2006, with a 
close to equal distribution of girls and boys (13,770 girls and 
14,288 boys), and with over three times as many 9 year-olds 
as 12 year-olds (21,538 and 6520, respectively). Zygosity 
was determined by DNA sampling and use of questions on 
twin similarity (Hannelius et al. 2007). There were 7990 
monozygotic (MZ), 9744 dizygotic same sex (DZss), 9722 
dizygotic different sex (DZds) and 602 twins with unknown 
zygosity.
Measures
A‑TAC 
The telephone interview in CATSS includes the Autism-
Tics, ADHD and other Comorbidities (A-TAC), which is 
a fully structured interview designed to be used by laymen 
over the telephone. It consists of 96 questions, 17 of which 
correspond to the “ASD module”, 19 to the “ADHD mod-
ule”, and 3 to the “LD module”. Each question has four 
response options: “no” (0), “yes, to some extent” (0.5), “yes” 
(1) or “I don’t know/I do not wish to answer” (missing). The 
A-TAC was developed based on the diagnostic criteria of 
DSM-IV, therefore its ASD module covers social interaction, 
language-communication, and flexibility-repetitive behavior 
problems in children, its ADHD module covers attention 
and activity/impulsiveness problems while the LD module 
measures learning difficulties in reading, writing and math-
ematical skills but does not exclude children with intellec-
tual disability. The ASD, ADHD and LD modules of A-TAC 
have been extensively validated against DSM-IV criteria and 
ICD codes F84.0, F84.1, F84.5 and F84.9 for ASD, F90 for 
ADHD and F70-F79 for LD (Hansson et al. 2005; Larson 
et al. 2013; Marland et al. 2017). Assessments of the pre-
dictive validity of these A-TAC modules have shown Areas 
Under the Curve (AUC) of 0.88 for ASD, 0.90 for ADHD 
and 0.74 for LD (fair to excellent overall validity) (Hans-
son et al. 2005). In the present study, the high cut-off of 
each module was used to identify children with these NDDs, 
providing higher specificity and lower sensitivity. For ASD, 
the cut-off of ≥ 8.5 has a specificity of 0.91 and a sensitivity 
of 0.61, for ADHD, the cut-off of ≥ 12.5 has a specificity 
of 0.93 and a sensitivity of 0.56 and for LDs, the cut-off 
= 3 has a specificity of 0.93 and a sensitivity 0.41 (Larson 
et al. 2010). Children meeting one or more of these cut-
offs constituted the “NDD group”, while the “Comparison 
group” consisted of twins who did not meet any of them. 
We excluded all children from the comparison group who 
fulfilled even the low cut-off criteria for ASD, ADHD or LD, 
with the purpose to provide a fully negative control group. 
Low cut-offs for ASD (≥ 4.5, specificity 0.88, sensitivity 
0.96), ADHD (≥ 6.0, 0.81/0.98) and LD (≥ 1.0, 0.75/0.88) 
were characterized by high sensitivity but lower specificity 
(Larson et al. 2010). To be able to view the specific ques-
tions asked, the English version of A-TAC can be accessed 
by visiting the following web page: http://gillb ergce ntre.
gu.se/digit alAss ets/1566/15665 33_a-tac_engli sh.pdf.
Physical Problems
Physical problems were also assessed during the tele-
phone interviews using questions requiring simple yes or 
no answers from the parents. Examples are: “Has he/she 
ever had any of the following diagnoses or disabilities”: 
Epilepsy? Migraine? Asthma? Cancer, tumor or leukemia? 
Diabetes? Psoriasis? Lactose intolerance? Celiac disease? 
Diarrhea? Constipation? In addition, two questions were 
used as proxies for daytime enuresis and for encopresis: 
“Has he/she during daytime wet himself/herself on several 
occasions after the age of five?” and Has he/she soiled him-
self/herself on several occasions after the age of four, except 
during gastroenteritis?
Study Groups
(a) The NDD group included children whose scores reached 
the high cut-offs for ASD and/or ADHD and/or LD. In this 
group, the total number of children was 1021 [21% MZ 
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twins, 672 (66%) boys and 349 (34%) girls]. Within this 
group, analyses of mutually exclusive separate diagnoses 
(ASD: 91 children, ADHD: 377 children and LD: 294 chil-
dren) as well as by different constellations of several NDD 
diagnoses were conducted (ASD and ADHD n = 108, ASD 
and LD n = 50, ADHD and LD n = 49 and finally ASD and 
ADHD and LD n = 52). (b) The comparison group included 
children whose scores did not reach the low cut-offs in any 
of the ASD, ADHD or LD domains. This population con-
sisted of 22,028 children (29% MZ twins, 10,653 (48%) 
girls and 11,375 (52%) boys). Categories are summarized 
in Fig. 1.
Analyses
Statistical Analyses
Statistical analyses were performed using SPSS version 21. 
The Pearson Chi square or the Fisher´s exact tests were used 
to test for statistical significance between the prevalences of 
defined physical problems in groups and subgroups. P-val-
ues < 0.05 were considered statistically significant. Odds 
ratios (ORs), which were calculated from descriptive statis-
tics, cross-tabulations, and by clicking risk and Cochran’s 
and Mantel-Haenzsel statistics in SPSS, were reported with 
95% confidence interval. Figures were graphed using Graph-
Pad Prism 7 software.
Results
Prevalence of Physical Problems in the General 
Population
In this population of 9 or 12 year-old children, asthma 
had the highest prevalence (14.2%), followed by daytime 
enuresis (7.4%), encopresis (4.0%), and migraine (3.5%). 
Of the GI problems, the most prevalent was constipation 
(8.4%) and lactose intolerance (5.9%) (Figs. 2a–f, 3a–f). 
All physical problems were more common among children 
who screened positive for any NDD than among their screen 
negative peers.
Prevalence of Physical Problems in the Groups 
with a Single NDD
Generally, children with NDDs had an elevated prevalence 
of most types of physical conditions, although not all of 
them reached statistical significance compared to the com-
parison group. The prevalence of physical problems in the 
defined groups is summarized in Figs. 2a–f and 3a–f, and 
detailed in the Supplementary material, Table 1.
Children who screened positive for a single NDD had 
significantly higher prevalences of epilepsy, diarrhea, con-
stipation, daytime enuresis and encopresis (p < 0.001). For 
Fig. 1  Flowchart of the study groups. In the present study, A-TAC 
high cut-offs were used as clinical proxies for ASD, ADHD and 
LD, which are included in the NDD group. The comparison group 
included only children who did not fulfill the low cut-off of any NDD. 
A-TAC autism-tics, ADHD and other comorbidities, NDD neurode-
velopmental disorders, ASD autism spectrum disorder, ADHD atten-
tion-deficit/ hyperactivity disorder; LD learning disorder
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children with ASD, the OR of epilepsy and encopresis were 
the highest compared to comparison group, OR 9.9 for epi-
lepsy and 12.1 for encopresis although prevalence of enu-
resis was the highest in the group (38.5%). Children who 
screened positive for LD only had significantly higher risk of 
epilepsy (OR 15) and cancer (OR 3.9), even though asthma, 
celiac disease, diarrhea, constipation, daytime enuresis and 
encopresis were also significantly more common than among 
controls. ADHD was associated with epilepsy, asthma, lac-
tose intolerance, diarrhea, constipation, daytime enuresis 
and encopresis (p < 0.001) (supplementary material).
Prevalence of Physical Problems in the Groups 
with Multiple NDDs
Children with a constellation of two or three NDDs more 
often reported physical problems than children with one 
NDD. However, there were no differences in the prevalence 
of physical problems between children with two versus all 
three NDDs. Some of the NDD constellations were associ-
ated with markedly increased prevalence of some specific 
physical problems. For example, children diagnosed with 
ASD and LD had an over 36 times increase in the preva-
lence of epilepsy (Fig. 2a, OR 36.2), six times increase in 
the prevalence of constipation (Fig. 3d, OR 6.2), almost 14 
times increased prevalence of daytime enuresis (Fig. 3.d, OR 
13.8), and over 17 times increased prevalence of encopresis 
(Fig. 3.e, OR 17.8). The coexistence of ASD and ADHD 
increased the odds for epilepsy (Fig. 2.a, OR 5.2) migraine 
(Fig. 2b, OR 3.2), asthma (Fig. 2c, OR 2.6), cancer (Fig. 2d, 
OR 5.2), diarrhea (Fig. 3c, OR 6.0), constipation (Fig. 3d, 
OR 3.4), daytime enuresis (Fig. 3e, OR 6.6), and encopresis 
(Fig. 3f, OR 10.4). In the group of children who were screen-
positive for both ADHD and LD, the prevalence of diabetes 
was 15 times increased (Fig. 2e, OR 15.9) compared to the 
comparison group.
Discussion
In this study, we found increased rates of physical problems 
in Swedish twins screening positive for NDDs as compared 
to controls. In particular, epilepsy, migraine, asthma, diar-
rhea, constipation, daytime enuresis and encopresis were 
overrepresented in children who were screen-positive for 
NDDs. These results are generally in line with previous stud-
ies finding increased rates of physical problems in children 
with NDDs (Amiet et al. 2008; Batista et al. 2012; Kohane 
et al. 2012; McKeown et al. 2013; Schieve et al. 2012). Our 
study advances the field showing that children with different 
constellations of NDDs more often had coexisting physical 
problems as compared to children with a single NDD. More-
over, our study indicates that some specific combinations 
carry higher risk of specific physical problems, which has 
been difficult to assess by the existing literature that has 
mostly examined the relationship between physical problems 
and specific NDDs.
Recently, the well-documented association between child-
hood epilepsy and ASD has been confirmed using the same 
twin study population as the present study (Gillberg et al. 
2017). However, our results indicate that children with LD 
and especially children with both ASD and LD have the 
highest prevalence of epilepsy (OR 53), and that as many as 
1/5 of them may be affected in childhood. The association 
between ASD and epilepsy may be partially mediated by the 
presence of LD or intellectual disability, also supported by 
previous research (Amiet et al. 2008).
Migraine and ASD include some symptomatic similari-
ties, e.g. many children with ASD have sensory hypersensi-
tivity (Sullivan et al. 2014), many migraine patients report 
symptoms such as photophobia during headache attacks 
(Hansen et al. 2015), and a recent study provides some 
preliminary evidence for a link between migraine, sensory 
hypersensitivity and anxiety in ASD (Sullivan et al. 2014). 
In the present study we found significant increase in the 
prevalence of migraine in children with ASD, ADHD and 
their combination as compared to the prevalence found in 
children without any NDD. It has been reported that some 
anti-migraine medications (which act through increasing 
serotonergic activity) can improve repetitive behavioral 
symptoms of autism (Hollander et  al. 2000). Consider-
ing the overlap of migraine with ADHD, it has previously 
been suggested that migraine is not comorbid with ADHD 
in children, but with their hyperactive-impulsive behaviors 
(Arruda et al. 2010). In adult ADHD patients, the risk of 
migraine is increased by about 70% (Fasmer, Halmoy, Oede-
gaard, et al., 2011) which is a very similar increase to what 
was found here (OR 1.8). Also, the prescription pattern for 
anti-migraine medications and drugs for the treatment of 
ADHD in adults seems to indicate a link between migraine 
and ADHD (Fasmer et al. 2012).
Asthma was found to be very common among children 
with NDDs in our study, being most prevalent in children 
with both ADHD and LD where nearly one-third reported 
asthma. An American national survey on children below the 
age of 17 with a diagnosis of asthma, found, in line with 
our results, that asthma was independently associated with 
ADHD and LD (Blackman and Gurka 2007). Moreover, a 
study by Chen and co-workers indicated that asthma in early 
life among Taiwanese children predispose for ADHD later 
(Chen et al. 2013). The converse may also be true as studies 
indicate that ADHD is affected by regulation of the auto-
nomic nervous system (Ward et al. 2015).
The association between cancer and central nervous sys-
tem disorders has been explored in several population-based 
studies (Crawley et al. 2016; Driver et al. 2012; Ji et al. 
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2013). In our study, 1.3% of children with “any NDD” (as 
compared to 0.3% of children from the comparison group) 
had a parent-reported cancer history. Our result should be 
interpreted with caution as the number of individuals report-
ing cancer was small and that only living children were 
included. The link between cancer and NDD might specu-
latively be mediated through the various cancer treatments 
such as cranial radiation (Edelstein et al. 2011), even though 
we did not specifically monitor such treatments. A review by 
Anderson and co-workers indicated that even chemotherapy 
alone (without CNS irradiation) during childhood may have 
subtle long-term effects on attention and executive function-
ing later in life (Anderson and Kunin-Batson 2009). There 
may also be shared etiological factors, such as increased 
prevalence of mutations in PTEN (phosphatase and tensin 
homolog) that has been observed in ASD (McBride et al. 
2010). PTEN is normally involved in regulating signaling 
pathways in cell proliferation and apoptosis (Worby and 
Dixon 2014) and mutations in PTEN could therefore theo-
retically increase the risk of cancer. In addition, it is also 
well known that many children with tuberous sclerosis (a 
proliferative genetic condition) develop ASD and/or have 
LD and a range of other developmental problems often con-
ceptualized as “tuberous sclerosis-associated neuropsychiat-
ric disorders” (de Vries et al. 2015). Similarly, in our study 
we found increased prevalence of cancer among children 
with ASD (1.1%) or LD (1.4%).
As previously mentioned, research has shown a link 
between maternal inflammatory conditions during preg-
nancy and offspring risk for NDDs (Ginsberg et al. 2017), 
both in mouse models (Mottahedin et al. 2017) and in clini-
cal settings (Goines et al. 2011; Jiang et al. 2016). One study 
showed an association between maternal and paternal history 
of T1DM and ASD (Atladottir et al. 2009), while other stud-
ies indicate a possible link between autism and T1DM where 
0.9% of children with T1DM in a tertiary hospital were also 
diagnosed with autism (Freeman et al. 2005). In our study, 
0.4% of the comparison group (consisting of 22,028 chil-
dren) screened positive for diabetes, and the prevalence of 
diabetes was significantly increased in children with NDD, 
especially ADHD. Studies have also shown significantly 
higher occurrence of autoimmune diseases (mainly hypo-
thyroidism and rheumatic fever) in relatives of children 
with ASD, even higher than among family members to chil-
dren with autoimmune disease (Sweeten et al. 2003). In a 
Swedish nationwide register-based cohort study in Sweden 
(Butwicka et al. 2017), children with biopsy-verified diag-
nosis of celiac disease had a 1.4-fold greater risk for mood 
disorders, anxiety disorders, eating disorders, behavioral dis-
orders, ADHD, ASD, and intellectual disability compared to 
the general population. In contrast, siblings of celiac disease 
probands were at no increased risk for any of the investigated 
psychiatric disorders. These results are in alignment with our 
findings that suggest a possible link between autoimmune 
disorders such as celiac disease and NDDs.
Our findings included the strong positive association 
found between NDDs and GI problems, that is in line with 
a recent review on the association between ASD and gut 
microbiota (Li et al. 2017). Research indicates that the gut is 
physiologically related to the brain through the vagal nerve 
and the enteric nervous system, and that increases in the 
sympathetic tone, such as stress or anxiety, may decrease 
bowel movement in humans. Previous research has found a 
partial relationship between GI problems and higher level 
of anxiety (Mazefsky et al. 2014), sensory hyperactivity 
among children with NDDs (Mazurek et al. 2013), as well 
as increased heart rate variability and GI symptoms in chil-
dren with ASD compared to controls (Ferguson et al. 2016). 
Whether these hypotheses can be extended to ADHD and/
or LD remains to be better elucidated, but some results such 
as those presented here indicate that they probably can be.
The prevalence of daytime enuresis and encopresis in the 
present study was up to 50% in the NDD groups. The treat-
ment of enuresis and encopresis in children with ASD, with 
or without LD, is very important (von Gontard et al. 2015). 
It has been shown that multimodal and individualized treat-
ment in children with ADHD can treat the voiding symptoms 
(Kaye and Palmer 2010). One study indicated that children 
with ADHD and enuresis are less likely than children without 
ADHD to be brought to medical attention for their voiding 
problems (Shreeram et al. 2009). It is important to actively 
ask about incontinence because many children and/or their 
families may not easily report such problems. Many children 
with LD or autism also have impaired communicative abili-
ties, which may further contribute to the high prevalence of 
enuresis and encopresis that we found in our study. We know 
that daytime enuresis and encopresis are common among 
school children with a prevalence of daytime enuresis among 
Swedish 10 year-olds estimated to be around 4%, while that 
for fecal incontinence/soiling is 7% in boys and 4% in girls 
(based on parental questionnaires), (Soderstrom et al. 2004). 
The prevalence of enuresis and encopresis reported in previ-
ous studies are highly variable due to different definitions and 
ascertainment (Peeters et al. 2013; Simonoff et al. 2008). Esti-
mated prevalences of enuresis range from 5 to 43% in children 
with ADHD (Gor et al. 2012; Niemczyk et al. 2015; Robson 
et al. 1997; Shreeram et al. 2009) and from 11 to 55% among 
children with ASD (Gor et al. 2012; Simonoff et al. 2008; 
Fig. 2  The figures show the prevalence of epilepsy (a), migraine 
(b), asthma (c), cancer (d), diabetes (e) and psoriasis (f) in our study 
groups and the statistical comparison to the comparison group con-
sisting of twins who screened negative for neurodevelopmental dis-
orders. Statistical significance is marked by stars, where p < 0.05 is 
represented by *, p < 0.01 by ** and p < 0.001 by ***. NDDs neu-
rodevelopmental disorders, ASD autism spectrum disorder, ADHD 
attention-deficit/hyperactivity disorder and LD learning disorder
◂
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Taira et al. 1998). One study reported that almost one-third 
of pediatric patients with functional defecation disorder in a 
specialized outpatient setting had concomitant ASD symptoms 
(Peeters et al. 2013). Compared to prevalence estimates shown 
so far, our results are generally in line with earlier research and 
also indicate an increased risk for incontinence if the child has 
several NDDs.
Clinical implications
It is known that comorbid physical conditions alter develop-
mental trajectories (Hedvall et al. 2015). In agreement with 
the ESSENCE concept (Gillberg 2010, 2014) highlighting 
the significant amount of overlap across NDDs (Gillberg 
2010), we recommend heightened awareness of the need 
for full medical/physical clinical examinations of children 
with NDDs.
We also recommend healthcare workers to specifically 
ask about GI problems and daytime enuresis as well as enco-
presis since these problems may be widespread in children 
with NDDs, causing medical and major social problems for 
the children and their families (Butler and Heron 2008). We 
also believe that it is of clinical importance to focus on all 
the different constellations of NDDs since our results indi-
cate that these may be differently associated with physical 
problems.
Conclusions
• Children with ASD, ADHD and/or LD have a high 
prevalence of physical comorbidities such as epilepsy, 
migraine, asthma, GI complications and incontinence.
• Our results indicate possible association between physi-
cal problems and constellations of NDDs as compared to 
single NDD diagnoses.
Strengths and Limitations
Our study should be interpreted in the context of some 
strengths and limitations. The data are based on parental 
reports on psychiatric and physical problems and not on clini-
cal assessment of the children, which is an obvious limitation. 
NDDs were assessed as proxy diagnoses using an instrument 
that was developed and validated for the purpose, the A-TAC 
(Hansson et al. 2005; Larson 2013; Larson et al. 2010, 2013). 
Regarding physical problems, simple questions have been used 
to detect the existence of these problems. This means that we 
did not have access to data that could disentangle and specify 
different subcategories of each problem type/diagnosis such 
as subtypes of epilepsy or of migraine. Previous validation 
studies have shown that simple questionnaires can be sufficient 
for screening purposes of at least some physical problems on 
population level (Gervil et al. 1998).
Our study population consisted of twins. Many twins are 
born preterm and there is an established association between 
prematurity and NDDs. However, although we did not cor-
rect for prematurity, we did not find a higher prevalence of 
NDDs (ASD 1.1%, ADHD, 2.1% and LD 1.6%) in our twin 
register similar to previous studies on twins (Croen et al. 2002; 
Hallmayer et al. 2002; Hultman et al. 2002). The strengths 
of our study are the very large study population and that it is 
systematically derived from the general population. The over-
lap between two conditions can be causative in either direc-
tion or due to shared susceptibility factors. It was beyond the 
scope of this article to investigate such confounding factors, 
e.g. pre-, peri- and postnatal factors in autism (Hisle-Gorman 
et al. 2018) or shared heritability.
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